tirzepatide elimination half life Mean (one-sided standard deviation) plasma concentration profile of TrimRX | Tirzepatide Results Timeline:

"As we move into 2026, these insights will provide the foundation for our initial entry into longevity." The company aims to capitalize on growing interest for treatments related to immunity, recovery and improved metabolic function

Not an approved study

Your healthcare provider will discuss the potential benefits and risks with you to make an informed decision

"We believe each of these initiatives is laying the foundation for a future where a membership at Hims & Hers will cover the majority of conditions that impact an individual's everyday health

what sets us apart is our commitment to coaching and offering personalized support while you are under a medically supervised weight loss treatment plan